Analyst firms · Piper Sandler · TEAM
Piper Sandler TEAM price target and rating history
Atlassian Corporation (TEAM) · Technology
Piper Sandler rates Atlassian Corporation (TEAM) Overweight with a $225 price target, as of its latest action on Jul 2, 2024. It has published 4 rating actions on TEAM since July 2021, including 1 upgrade and 1 downgrade. Across 5 firms with a TEAM price target in the last 12 months, the median target is $175.
- Current rating
- Overweight
- Price target
- $225
- Median target, all firms
- $175
- Actions on TEAM
- 4
Piper Sandler price target on TEAM
Every Piper Sandler rating on TEAM
- Jul 2, 2024
- Nov 4, 2022
- Oct 29, 2021
- Jul 30, 2021
How other firms rate TEAM
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| RBC Capital Markets | Outperform | $215 | Aug 26, 2026 |
| BofA Securities | Buy | $175 | Aug 7, 2026 |
| BMO Capital Markets | Outperform | $175 | Aug 7, 2026 |
| BNP Paribas Exane | Outperform | $95 | Mar 16, 2026 |
| BTIG | Buy | $220 | Dec 17, 2025 |
Questions about Piper Sandler and TEAM
- What is Piper Sandler's price target for TEAM?
- Piper Sandler's latest stated price target for Atlassian Corporation (TEAM) is $225, from its action on Jul 2, 2024.
- What is Piper Sandler's rating on TEAM?
- Piper Sandler rates TEAM Overweight, a bullish rating, as of Jul 2, 2024.
- When did Piper Sandler last change its view on TEAM?
- On Jul 2, 2024, Piper Sandler upgrades to Overweight from Neutral, price target $200 to $225.
- How does Piper Sandler's TEAM target compare with other analysts?
- Across 5 firms with a TEAM price target in the last 12 months, the median target is $175.
More TEAM rating histories
- BMO Capital Markets12
- Capital One3
- Robert W. Baird3
- Macquarie3
- Truist Securities3
- KeyBanc Capital Markets3
- Goldman Sachs4
- TD Cowen6
- Wolfe Research3
- Mizuho4
All Piper Sandler ratingsTEAM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.